Multiple-line chemotherapy for a patient with unresectable mucinous cystic neoplasm of the pancreas

3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We diagnosed her with an unresectable mucinous cystic neoplasm, since ascites cytology revealed adenocarcinoma. The patient received chemotherapy up to the fifth line for 55.2 months. Gemcitabine plus nabpaclitaxel and modified FOLFIRINOX achieved a partial response with a progression-free survival time of 12.1 and 20.4 months, respectively. The overall survival time from the beginning of first-line chemotherapy was 69.4 months.

Cite

CITATION STYLE

APA

Miwa, H., Sugimori, K., Ishii, T., Funaoka, A., Tsuchiya, H., Suzuki, Y., … Maeda, S. (2021). Multiple-line chemotherapy for a patient with unresectable mucinous cystic neoplasm of the pancreas. Internal Medicine, 60(16), 2607–2612. https://doi.org/10.2169/internalmedicine.6755-20

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free